Axonic Capital Hires Michael Gordon as Head of Insurance Solutions
Axonic Capital, New York-based structured credit, commercial real estate, and systematic fixed income specialist with $4.8 billion in assets under management, announced the addition of Michael Gordon, who will build out Axonic’s Insurance Solutions business.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220802006037/en/
Michael Gordon - Head of Insurance Solutions at Axonic Capital (Photo: Business Wire)
Axonic’s Insurance Solutions business is focused on providing capital and investment solutions that match liabilities for the benefit of policyholders and other stakeholders. Mr. Gordon will be responsible for leading Axonic’s insurance investments, strategic partnerships, and other transactions with insurance companies.
Mr. Gordon has over two decades of experience predominantly focused within the insurance and investment management markets. Prior to joining Axonic Mr. Gordon was US Chief Executive Officer and Group Chief Operating Officer at Lombard International.
“We are pleased to welcome Michael as a key addition to our leadership team during a time of increasing growth for our business. He brings invaluable experience that will benefit our longstanding institutional investors and support the development of new partnership and investment opportunities as we further grow our insurance platform,” said Clay DeGiacinto, Chief Investment Officer and Managing Partner of Axonic.
“Axonic's platform is well built to service the current and future needs of insurance companies leveraging our extensive expertise across commercial real estate and structured credit. The Axonic Insurance Solutions Business will partner with leading insurers to develop portfolios with high-quality investments that generate attractive risk-adjusted returns for insurers, policyholders, beneficiaries and other stakeholders.”
Prior to joining Lombard International, Mr. Gordon served as the Global Head of Insurance Solutions at BNY Mellon Investment Management. Prior to BNY Mellon, he was an executive at New York Life Insurance Company, leading investment and insurance product management, including sales and marketing, actuarial, operational, and technology functions, as well as overseeing the Broker Dealer and the Registered Investment Advisor for the U.S. life insurance business.
Mr. Gordon earned his B.A. in Philosophy from Colgate University.
About Axonic Capital
Founded in 2010, Axonic Capital offers commercial and residential real estate strategies, systematic fixed income and commercial lending strategies along with its structured credit expertise. Axonic Capital manages investment portfolios across Limited Partnerships, Separate Accounts, and two publicly registered Funds. The firm employs 56 professionals.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802006037/en/
Contact information
Axonic Capital Media:
Melissa Parvis
+1 212 828 7209
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NextPower V ESG Reaches $745 Million To Date29.4.2024 09:30:00 EEST | Press release
NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector, is delighted to announce the conclusion of its second close of $265 million for its fifth strategy, NextPower V ESG (“NPV ESG”). NPV ESG is an OECD-focused solar and battery storage strategy targeting $1.5 billion with a $2 billion hard cap that has secured $745 million in total commitments to date. The new capital includes commitments from a UK LGPS investment pool, a Dutch pension fund, and another re-up from an existing NextPower III ESG investor. These new investors join existing NPV ESG investors KLP, a German occupational pension fund, and a large Nordic pension fund. NPV ESG will continue welcoming further capital, with several investors currently active in due diligence. NPV ESG’s investment strategy targets the solar+ infrastructure sector in carefully selected OECD markets, with the objective of building significant portfolios in each target market, establishing an
H2SITE’s AMMONIA to H2POWER Technology Receives Approval in Principle From Lloyd’s Register29.4.2024 09:30:00 EEST | Press release
Ammonia cracking is gaining momentum as a potential hydrogen carrier for onboard applications and this system is based on H2SITE’s hydrogen-selective membranes that overcome the thermodynamic limitations of the ammonia cracking reaction by recovering hydrogen continuously and resulting in virtually complete ammonia conversion and higher efficiencies at lower temperatures, reducing overall energy consumption and footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428422597/en/ (Photo: Business Wire) In awarding the AIP, the design and arrangement evaluation included an overall examination of fundamental aspects of the design and compliance with LR’s Rules and Regulations for the Classification of Ships using Gases or other Low-flashpoint Fuels. A preliminary appraisal of rules was undertaken, followed by a risk assessment conducted to ensure that the risks arising from the use of ammonia and hydrogen are addressed ac
Geopolitical Stability, Inclusive Growth, Energy Security Under Spotlight in Riyadh at World Economic Forum Special Meeting29.4.2024 08:46:00 EEST | Press release
Riyadh convened global leaders today at the World Economic Forum Special Meeting on Global Collaboration, Growth and Energy for Development to host candid dialogues and outline bold steps to tackle the most pressing geopolitical, social and economic challenges facing humanity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428317713/en/ His Excellency Faisal Alibrahim, Saudi Minister of Economy and Planning, welcomes global leaders to Riyadh for the World Economic Forum Special Meeting on Global Collaboration, Growth and Energy for Development. (Photo: AETOSWire) Speaking at the Special Meeting, His Royal Highness Prince Abdulaziz bin Salman bin Abdulaziz Al Saud, Minister of Energy for Saudi Arabia, said a just and equitable energy transition will only be achieved by using a range of energy sources to diversify the global energy market. Access to secure and reliable energy, he said, is crucial to enabling people and comm
4P-Pharma Announces Total Capital of €15 Million Successfully Secured in Second Closing29.4.2024 07:40:00 EEST | Press release
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424933193/en/ (Graphic: Business Wire) With this funding, 4P-Pharma's shareholders renew their confidence in the company's drug regeneration model for untreated serious diseases. They welcome the entry of Phase 2 clinical development of the two first 4P-Pharma's SPVs, underlying the robust potential of the company's business model. Revital Rattenbach, CEO of 4P-Pharma: "As CEO of 4P-Pharma, I am pleased with the renewed trust of our investors placed in our scientific and development approach year after year. This financial endorsement underscores our significant progress over the past decade. It attests to the str
PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA29.4.2024 07:17:00 EEST | Press release
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI PathFinder BCL2 Dx incorporates PROTEINA’s “SPID (Single-molecule Protein Interaction Detection)” technology, enabling high-sensitivity detection of protein-protein interaction (PPI) complexes of BCL2 family proteins and more accurate prediction of any PPI inhibitors targeting the BCL2 family. In this clinical validation, PPI PathFinder BCL2 Dx will be used to predict drug responsiveness in patients with Acute Myeloid Leukemia (AML), providing clinicians with guidance for more effective prescriptions of the widespread BCL2-targeted cancer drug “Venetoclax.” PROTEINA has previously conducted clinical validation of the same product domestically with the Hematologic Cancer Team at Seoul National University, and the findings are scheduled to be
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom